Insider Transactions in Q3 2024 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.03%
|
$21,000
$14.63 P/Share
|
|
Aug 12
2024
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
800
+0.3%
|
$10,400
$13.85 P/Share
|
|
Aug 06
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$26,000
$13.81 P/Share
|
|
Aug 05
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,500
+0.1%
|
$71,500
$13.18 P/Share
|
|
Aug 02
2024
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.38%
|
$15,000
$15.15 P/Share
|
|
Jul 23
2024
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.03%
|
$22,500
$15.89 P/Share
|
|
Jul 18
2024
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.38%
|
$16,000
$16.0 P/Share
|